Azacitidine 300 mg Tablets (Azashine 300) – Oncology Export Supplier

Azacitidine 300 mg tablets are prescription-only oral oncology medicines formulated for use within regulated cancer treatment frameworks. Marketed under the brand name Azashine 300, this product contains Azacitidine, a nucleoside analogue used in hematological oncology settings. Azacitidine 300 mg tablets are manufactured for hospital and institutional supply and are offered strictly for international export to licensed pharmaceutical distributors, hospitals, and oncology care institutions. AmeriDrugs does not supply this product for retail or direct patient use.

Active Ingredient

• Azacitidine – 300 mg per tablet
  Azacitidine is a pyrimidine nucleoside analogue utilized under approved oncology indications and administered under medical supervision.

Therapeutic Use

From an informational and regulatory perspective, Azacitidine 300 mg tablets are used in approved hematological oncology treatment settings, as defined by regulatory authorities in the importing country. This information is provided solely for product identification and international trade clarity. AmeriDrugs does not provide medical advice, treatment recommendations, or patient-level guidance related to Azacitidine 300 mg tablets.

Dosage Form

• Oral solid dosage form

• Film-coated tablets

• Supplied in unit-dose packaging suitable for hospital and institutional pharmacy use

• Administration and treatment decisions are determined exclusively by qualified oncology professionals in accordance with local regulations

Quality & Manufacturing Standards

Azacitidine 300 mg tablets (Azashine 300) are manufactured in GMP-compliant facilities operating under validated pharmaceutical quality management systems. Manufacturing processes include raw material qualification, in-process controls, and finished product testing to ensure identity, strength, purity, and consistency aligned with international export standards for Azacitidine 300 mg tablets.

Packaging Information

• Pack size: 14 tablets per box

• Pharmaceutical-grade blister packaging

• Secure secondary packaging designed for international transport

• Labeling compliant with prescription oncology medicine regulations

Target Buyers

This product is intended exclusively for supply to:

• Licensed pharmaceutical importers and distributors

• Hospitals and oncology treatment centers

• Government and private cancer care institutions

• Authorized healthcare procurement agencies

It is not intended for retail pharmacies, online consumer sales, or direct patient distribution.

Regulatory & Compliance Note

Azacitidine 300 mg tablets (Azashine 300) are prescription-only oncology medicines. Importation, distribution, and use must comply with the pharmaceutical laws, oral oncology drug regulations, and oncology approvals of the destination country. Buyers are responsible for ensuring regulatory compliance within their jurisdiction. AmeriDrugs operates solely as an export-focused pharmaceutical supplier and does not promote Azacitidine 300 mg tablets for self-medication or any non-regulated use.